Innealta Capital’s Altimmune ALT Stock Holding History

Innealta Capital’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-110	Closed	-$732	–	217
2024 Q2	$732	Buy	+110	New	+$812	﹤0.01%	1382

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Innealta Capital's ALT Position: Q3 2024 in Review

Innealta Capital sold out of Altimmune (ALT) in Q3 2024, closing a stake of 110 shares — an estimated $732 sold.

Innealta Capital first reported a position in ALT in Q2 2024 and held it in 1 quarter. The position peaked at $732 in Q2 2024. 169 funds tracked by Wall St. Rank hold ALT as of Q3 2024.

Innealta Capital reported no remaining Altimmune position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 110 Altimmune shares in Q3 2024, an estimated $732.
Innealta Capital first reported a position in Altimmune in Q2 2024 and held it in 1 quarter.
Innealta Capital's Altimmune position peaked at $732 in Q2 2024.
169 funds tracked by Wall St. Rank held Altimmune as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.